Balloon Angioplasty News and Research

RSS

Balloon Angioplasty is a procedure to enlarge the opening in a blood vessel that has become narrowed or blocked by plaque (a buildup of fat and cholesterol on the inner wall of the blood vessel). A small balloon is filled with air inside the blood vessel to push the plaque against the blood vessel wall and increase the opening.

Drug-coated balloon shows superiority in coronary in-stent restenosis treatment

In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) assessed the efficacy and safety of using a drug-coated balloon in patients undergoing coronary angioplasty.

11 Mar 2024

AI-driven algorithm accurately predicts death, complications after percutaneous coronary intervention

When a person has one or more blocked arteries, providers may choose to conduct a minimally invasive procedure known as percutaneous coronary intervention, or PCI.

17 Jan 2024

Cardiac rehabilitation linked to decreased risk of death after surgery

For millions of Americans who have heart surgery or experience cardiovascular complications, like heart attack or heart failure, they may be encouraged to participate in cardiac rehabilitation.

19 Jul 2023

Restoring blood flow to the legs reduces pain, improves quality of life for people with peripheral artery disease

Restoring blood flow to the legs, whether through bypass surgery or a less invasive artery-opening procedure with a stent, reduced pain and improved quality of life for people with peripheral artery disease (PAD), according to preliminary, late-breaking research presented today at the American Heart Association's Scientific Sessions 2022.

7 Nov 2022

Myocardial fibrosis linked to worse cardiovascular outcomes in patients with hypertension

A recent study conducted by the National Heart Centre Singapore (NHCS) discovered that myocardial fibrosis is associated with worse cardiovascular outcomes in patients with hypertension. Myocardial fibrosis is an important prognostic marker in the development of adverse cardiovascular events, such as heart failure and death.

21 Jul 2022

Novel ultrasound-assisted laser technique removes arterial plaque safely and efficiently

Atherosclerosis, a buildup of plaque, can lead to heart disease, artery disease, and chronic kidney disease and is traditionally treated by inserting and inflating a balloon to expand the artery.

24 May 2022

Study shows superiority of Chocolate Touch device for opening blocked arteries in the leg

Patients treated for a blocked artery in the leg were significantly more likely to have an open artery without further interventions at 12 months if they received the second-generation paclitaxel-coated balloon catheter known as the Chocolate Touch device compared with those receiving the commercially-available Lutonix drug-coated balloon catheter, according to a study presented at the American College of Cardiology's 71st Annual Scientific Session.

5 Apr 2022

Children's Hospital Los Angeles becomes first in the world to implant cardiac stent in babies

A Children's Hospital Los Angeles team has become the first in the world to implant a cardiac stent that's designed specifically for babies and young children and can be expanded all the way to adult size.

28 Feb 2022

Drugs derived from activated protein C may limit ischemia and reperfusion injury, study suggests

A University of South Florida Health preclinical study offers molecular insight into how activated protein C (APC) may improve aging patients' tolerance to reperfusion injury – a potentially adverse effect of treatment for ischemic heart disease.

31 Jan 2022

Pulmonary endarterectomy improves outcomes in patients with segmental disease

A new study, presented today at the AATS 101st Annual Meeting, found that patients treated surgically for segmental Chronic Thromboembolic Pulmonary Hypertension (CTEPH) had excellent outcomes with the vast majority doing very well in the long term without any additional treatment other than surgery.

3 May 2021

Ellipsys Vascular Access System reduces time for dialysis treatments

The Ellipsys Vascular Access System reduces the time before patients with kidney failure can start lifesaving dialysis treatments, while requiring fewer secondary procedures, according to a new study led by interventional radiologist Jeffrey Hull, M.D., of Richmond Vascular Center.

3 Sep 2020

Personalized genetic testing helps reduce adverse events following balloon angioplasty

An international, first-of-its-kind cardiology trial used personalized genetic testing to reduce by 34 per cent the number of serious adverse events following balloon angioplasty, a treatment for the most common form of heart disease.

26 Aug 2020

Ellipsys System can help create durable vascular access for end-stage renal disease

A new study shows significant benefits of the Ellipsys Vascular Access System in easily and safely creating durable vascular access for end-stage renal disease (ESRD) patients who require hemodialysis.

21 Jul 2020

Paclitaxel-coated devices used for widening blocked arteries not linked to increased mortality

Devices coated with a drug called paclitaxel that are used for widening blocked arteries in legs and feet are safe and not linked to an increase in deaths, according to a study of nearly 65,000 patients, published in the European Heart Journal today (Wednesday).

9 Oct 2019

Cardiac arrest survivor meets four Good Samaritans who saved his life one year after recovery

There was no time to spare when air passenger Hutz Hertzberg, DMin, PhD, suddenly collapsed at Midway Airport in full cardiac arrest.

29 Jun 2019

Researchers examine effects of prediabetes on cardiac risk of patients with CAD

Prediabetes, the precursor stage before type 2 diabetes, does not increase the cardiac risk of patients with coronary artery disease.

20 May 2019

Researchers examine coatings of drug-coated balloon catheters at microscopic levels

Drug-coated balloon catheters to open narrowed blood vessels and to deliver drugs to the impacted sites are used frequently for the treatment of peripheral arterial disease.

2 May 2019

New drug minimizes damage after a heart attack by 60 percent

Scientists have found a potential new drug for treating the heart damage caused by a heart attack by targeting the way the heart reacts to stress.

From Domainex 25 Apr 2019

FDA approves Intact Vascular’s Tack Endovascular System

Intact Vascular, Inc., a private medical device company committed to developing solutions for minimally invasive peripheral vascular procedures, today announced it received U.S. Food and Drug Administration approval for the Tack Endovascular System, a purpose-built dissection repair device implanted post-angioplasty in patients with peripheral arterial disease.

15 Apr 2019

Intact Vascular to present TOBA II pivotal clinical trial data at VIVA Conference

Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that data from its Tack Optimized Balloon Angioplasty II pivotal clinical trial will be presented at the 15th Annual VIVA Conference in Las Vegas, NV on November 5-8.

8 Oct 2018